Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/15/2023 | Singular Genomics Systems, Inc. | | Sale | Common Stock | 200k | $0.53 | $107k | By Domain Partners IX, L.P. | 08/11/2023 |
08/14/2023 | Singular Genomics Systems, Inc. | | Sale | Common Stock | 78k | $0.57 | $44.4k | By Domain Partners IX, L.P. | 08/11/2023 |
08/11/2023 | Singular Genomics Systems, Inc. | | Sale | Common Stock | 353.7k | $0.60 | $210.6k | By Domain Partners IX, L.P. | 08/11/2023 |
06/08/2023 | SERA PROGNOSTICS, INC. | SERA | Grant | Stock Option (right to buy) | 63.3k | $3.00 | $189.8k | | 06/08/2023 |
05/25/2023 | Singular Genomics Systems, Inc. | | Grant | Stock Option (Right to Buy) | 74k | $1.06 | $78.4k | | 05/25/2023 |
06/03/2022 | SERA PROGNOSTICS, INC. | SERA | Grant | Stock Option (right to buy) | 149.7k | $1.35 | $202.1k | | 06/03/2022 |
05/26/2022 | Singular Genomics Systems, Inc. | | Grant | Stock Option (Right to Buy) | 46.2k | $2.86 | $132.3k | | 05/26/2022 |
05/04/2022 | Evofem Biosciences, Inc. | EVFM | Grant | Stock option (right to buy) | 6k | $0.00 | $0 | | 05/04/2022 |
06/18/2021 | Evofem Biosciences, Inc. | EVFM | Purchase | Common Stock | 10k | $1.17 | $11.6k | | 06/18/2021 |
06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Series B Convertible Preferred Stock | 435.6k | $0.00 | $0 | By Domain Partners IX, L.P. | 06/01/2021 |
06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Series A Convertible Preferred Stock | 1.3M | $0.00 | $0 | By Domain Partners IX, L.P. | 06/01/2021 |
06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Series Seed Convertible Preferred Stock | 2.7M | $0.00 | $0 | By Domain Partners IX, L.P. | 06/01/2021 |
06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Common Stock | 4.4M | $0.00 | $0 | By Domain Partners IX, L.P. | 06/01/2021 |
05/12/2021 | Evofem Biosciences, Inc. | EVFM | Grant | Stock option (right to buy) | 90k | $1.25 | $112.5k | | 05/12/2021 |
09/16/2020 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option | 27.2k | $0.00 | $0 | | 09/16/2020 |
09/16/2020 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 27.2k | $0.77 | $21k | | 09/16/2020 |
06/12/2020 | Evofem Biosciences, Inc. | EVFM | Purchase | Common Stock | 5k | $2.94 | $14.7k | | 06/12/2020 |
05/12/2020 | Evofem Biosciences, Inc. | EVFM | Grant | Stock option (right to buy) | 50k | $5.06 | $253k | | 05/12/2020 |
08/06/2019 | ReShape Lifesciences Inc. | OBLN | Purchase | Warrants to Purchase Common Stock | 9.4k | $4.40 | $41.2k | | 08/06/2019 |
08/06/2019 | ReShape Lifesciences Inc. | OBLN | Purchase | Common Stock | 12.5k | $4.00 | $50k | | 08/06/2019 |
07/23/2019 | ReShape Lifesciences Inc. | OBLN | Grant | Common Stock | 78.1k | $0.00 | $0 | | 07/23/2019 |
06/05/2019 | Evofem Biosciences, Inc. | EVFM | Grant | Stock Option (Right to Buy) | 50k | $6.05 | $302.5k | | 06/05/2019 |
05/22/2019 | Evofem Biosciences, Inc. | EVFM | Other (acquisition) | Common Stock | 4.3k | $0.00 | $0 | | 05/21/2019 |
05/21/2019 | Evofem Biosciences, Inc. | EVFM | Sale | Common Stock | 655 | $5.07 | $3.3k | By Domain Associates, LLC | 05/21/2019 |
08/23/2018 | ReShape Lifesciences Inc. | OBLN | Purchase | Common Stock | 54.9k | $1.82 | $100k | | 08/23/2018 |
06/13/2018 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 81.8k | $2.36 | $193k | | 06/13/2018 |
05/08/2018 | Evofem Biosciences, Inc. | EVFM | Grant | Stock Option (Right to Buy) | 12.9k | $6.99 | $90k | | 05/08/2018 |
06/20/2017 | Evofem Biosciences, Inc. | EVFM | Grant | Stock Option (Right to Buy) | 12.4k | $2.19 | $27.3k | | 06/20/2017 |
06/06/2017 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 36.6k | $9.81 | $358.6k | | 06/06/2017 |
05/11/2017 | Evofem Biosciences, Inc. | EVFM | Grant | Stock Option (Right to Buy) | 63.5k | $2.15 | $136.5k | | 05/11/2017 |
05/09/2017 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 21k | $11.56 | $242.8k | | 05/09/2017 |
11/09/2016 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 46.5k | $8.74 | $406.4k | | 11/09/2016 |
10/31/2016 | Syndax Pharmaceuticals Inc | SNDX | Grant | Stock Option (Right to Buy) | 8k | $11.81 | $94.5k | | 10/31/2016 |
10/12/2016 | ReShape Lifesciences Inc. | OBLN | Purchase | Common Stock | 13.4k | $15.00 | $201k | | 10/12/2016 |
06/21/2016 | Evofem Biosciences, Inc. | EVFM | Grant | Stock Option (Right to Buy) | 24.6k | $1.13 | $27.8k | | 06/21/2016 |
|